Microsatellite instability:: Impact on cancer progression in proximal and distal colorectal cancers

被引:89
作者
Jernvall, P
Mäkinen, MJ
Karttunen, TJ
Mäkelä, J
Vihko, P
机构
[1] Univ Oulu, Bioctr, SF-90220 Oulu, Finland
[2] Univ Oulu, WHO, Collaborating Ctr Res Reprod Hlth, SF-90220 Oulu, Finland
[3] Univ Oulu, Dept Pathol, SF-90220 Oulu, Finland
[4] Univ Oulu, Dept Surg, SF-90220 Oulu, Finland
[5] Univ Helsinki, Dept Biosci, Div Biochem, FIN-00014 Helsinki, Finland
关键词
colorectal cancer; microsatellite instability; prognosis; replication errors; RER; survival;
D O I
10.1016/S0959-8049(98)00306-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Whilst individual planning of treatment and follow-up in every colorectal cancer case is an increasing demand, prognostic markers are needed for predicting cancer progression in the primary phase. We studied the effect of replication error (RER)-positivity on colorectal cancer progression by analysing 255 colorectal cancer specimens by polymerase chain reaction (PCR) and fragment analysis and correlating the results with the clinical and histological features of the tumour and with patient outcome. RER-positivity was detected in 12% (28/235) of cases. It was associated with proximal location of the tumour (P<0.001), poor differentiation (P=0.001) and large tumour size (P=0.009). The 5-year cumulative survival rate of the patients with RER-positive cancer of the proximal colon was markedly better (100%) than that of those with RER-negative proximal cancer (74%), whilst in cases of cancer of the distal colon or rectum, RER-positivity (21%) indicated poorer survival than RER-negativity (57%). Thus, it is suggested that RER-positivity has an opposite impact on cancer progression in cases of proximal and distal cancers. RER-positivity appears to indicate improved prognosis only in cases of proximally located cancer, in which it could accordingly be useful as a prognostic marker. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 49 条
[11]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154
[12]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[13]   MUTATED HUMAN ANDROGEN RECEPTOR GENE DETECTED IN A PROSTATIC-CANCER PATIENT IS ALSO ACTIVATED BY ESTRADIOL [J].
ELO, JP ;
KVIST, L ;
LEINONEN, K ;
ISOMAA, V ;
HENTTU, P ;
LUKKARINEN, O ;
VIHKO, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3494-3500
[14]  
ESHLEMAN JR, 1995, ONCOGENE, V10, P33
[15]  
GRAHAM DM, 1990, MODERN PATHOL, V3, P332
[16]  
HAN HJ, 1993, CANCER RES, V53, P5087
[17]   LOSS OF THE WILD-TYPE MLH1 GENE IS A FEATURE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER [J].
HEMMINKI, A ;
PELTOMAKI, P ;
MECKLIN, JP ;
JARVINEN, H ;
SALOVAARA, R ;
NYSTROMLAHTI, M ;
DELACHAPELLE, A ;
AALTONEN, LA .
NATURE GENETICS, 1994, 8 (04) :405-410
[18]   UBIQUITOUS SOMATIC MUTATIONS IN SIMPLE REPEATED SEQUENCES REVEAL A NEW MECHANISM FOR COLONIC CARCINOGENESIS [J].
IONOV, Y ;
PEINADO, MA ;
MALKHOSYAN, S ;
SHIBATA, D ;
PERUCHO, M .
NATURE, 1993, 363 (6429) :558-561
[19]  
Jass JR., 1989, HISTOLOGICAL TYPING
[20]  
Jernvall P, 1997, INT J CANCER, V74, P97, DOI 10.1002/(SICI)1097-0215(19970220)74:1<97::AID-IJC17>3.0.CO